381 related articles for article (PubMed ID: 8886845)
1. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
[TBL] [Abstract][Full Text] [Related]
2. [Exploration of high expressions of retroviral vectors containing hFIX minigene in murine myoblast cells].
Hou J; Wang J; Min B
Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):121-4. PubMed ID: 11877060
[TBL] [Abstract][Full Text] [Related]
3. Hybrid retroviral vector with MCK enhancers inserted in LTR for stable and specific expression of human factor IX in skeletal muscle.
Wang JM; Hou J; Qiu XF; Kurachi K; Xue JL
Chin Med J (Engl); 2004 Jun; 117(6):893-8. PubMed ID: 15198894
[TBL] [Abstract][Full Text] [Related]
4. Persistent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer: feasibility of repeat application to obtain therapeutic levels.
Wang JM; Zheng H; Blaivas M; Kurachi K
Blood; 1997 Aug; 90(3):1075-82. PubMed ID: 9242538
[TBL] [Abstract][Full Text] [Related]
5. Retroviral vector sequences may interact with some internal promoters and influence expression.
Wu X; Holschen J; Kennedy SC; Ponder KP
Hum Gene Ther; 1996 Jan; 7(2):159-71. PubMed ID: 8788167
[TBL] [Abstract][Full Text] [Related]
6. Increment of hFIX expression with endogenous intron 1 in vitro.
Zheng B; Qiu XY; Tan M; Xing YN; Lo D; Xue JL; Qiu XF
Cell Res; 1997 Jun; 7(1):21-9. PubMed ID: 9261559
[TBL] [Abstract][Full Text] [Related]
7. Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system.
Wahlfors JJ; Morgan RA
Hum Gene Ther; 1999 May; 10(7):1197-206. PubMed ID: 10340551
[TBL] [Abstract][Full Text] [Related]
8. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice.
Yao SN; Smith KJ; Kurachi K
Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074
[TBL] [Abstract][Full Text] [Related]
9. Effects of a second intron on recombinant MFG retroviral vector.
Malik AK; Wang JM; Kurachi K
Arch Virol; 2001; 146(3):601-9. PubMed ID: 11338393
[TBL] [Abstract][Full Text] [Related]
10. Genetic modification of bone-marrow mesenchymal stem cells and hematopoietic cells with human coagulation factor IX-expressing plasmids.
Sam MR; Azadbakhsh AS; Farokhi F; Rezazadeh K; Sam S; Zomorodipour A; Haddad-Mashadrizeh A; Delirezh N; Mokarizadeh A
Biologicals; 2016 May; 44(3):170-7. PubMed ID: 26928674
[TBL] [Abstract][Full Text] [Related]
11. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.
Miao CH; Thompson AR; Loeb K; Ye X
Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human factor IX expression using doxycycline-inducible gene expression system.
Srour MA; Fechner H; Wang X; Siemetzki U; Albert T; Oldenburg J; Hanfland P; Poller W; Brackmann HH; Schwaab R
Thromb Haemost; 2003 Sep; 90(3):398-405. PubMed ID: 12958607
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of recombinant adeno-associated virus-mediated gene transfer.
Malik AK; Monahan PE; Allen DL; Chen BG; Samulski RJ; Kurachi K
J Virol; 2000 Apr; 74(8):3555-65. PubMed ID: 10729130
[TBL] [Abstract][Full Text] [Related]
14. Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter.
Hagstrom JN; Couto LB; Scallan C; Burton M; McCleland ML; Fields PA; Arruda VR; Herzog RW; High KA
Blood; 2000 Apr; 95(8):2536-42. PubMed ID: 10753832
[TBL] [Abstract][Full Text] [Related]
15. High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors.
Miao CH; Ye X; Thompson AR
Hum Gene Ther; 2003 Sep; 14(14):1297-305. PubMed ID: 14503965
[TBL] [Abstract][Full Text] [Related]
16. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
Couture LA; Mullen CA; Morgan RA
Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
[TBL] [Abstract][Full Text] [Related]
17. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.
Nathwani AC; Davidoff A; Hanawa H; Zhou JF; Vanin EF; Nienhuis AW
Blood; 2001 Mar; 97(5):1258-65. PubMed ID: 11222368
[TBL] [Abstract][Full Text] [Related]
19. A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers.
Ferrari G; Salvatori G; Rossi C; Cossu G; Mavilio F
Hum Gene Ther; 1995 Jun; 6(6):733-42. PubMed ID: 7548273
[TBL] [Abstract][Full Text] [Related]
20. Construction and its expression of a new retroviral vector containing a human blood coagulation factor IX cDNA.
Matsushita T; Emi N; Takahashi I; Takamatsu J; Saito H
Thromb Res; 1993 Feb; 69(4):387-93. PubMed ID: 8470060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
